1. Home
  2. Directory
  3. Louisiana
  4. Metairie
  5. Oral Maxillofacial Surgery
  6. NPI Profile
  7. Prescriptions 1619209939

DANIEL MARSHALL CUMMINS M.D., D.M.D
Prescription History 1619209939
Oral & Maxillofacial Surgery in Metairie, LA

NPI Status: Active since February 11, 2010

Contact Information

4224 HOUMA BLVD
SUITE 670
METAIRIE, LA
ZIP 70006
Phone: (504) 456-5033

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DANIEL MARSHALL CUMMINS M.D., D.M.D, an active Oral & Maxillofacial Surgery specialist practicing in Metairie, LA. Our medical registry currently tracks 6 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 216 documented patient claims. Among these therapy options, the most frequently utilized medication is Dexamethasone, which accounts for 102 claims alone.

Medication Index

Chlorhexidine Gluconate

Generic Formulation: Chlorhexidine GluconateSpecialty: Otolaryngology
Provider Metrics Summary
Total Claims 50
30-Day Fills 51.1
Days Supply 797
LA State Average Benchmarks
Peer Average Claims40.0
Peer Average 30-Day Fills41.2
Peer Average Days Supply762
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across LA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $591.28 across this reporting matrix range.

Provider Avg Cost Per Claim

$11.83

State Avg Cost Per Claim

$5.80

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used along with regular tooth brushing/flossing to treat gingivitis, a gum disease that causes red, swollen, and easily bleeding gums. Chlorhexidine belongs to a class of drugs known as antimicrobials. It works by decreasing the amount of bacteria in the mouth, helping to reduce swelling and redness of the gums and bleeding when you brush.

Dexamethasone

Generic Formulation: DexamethasoneSpecialty: Otolaryngology
Provider Metrics Summary
Total Claims 102
30-Day Fills 117.4
Days Supply 2,747
LA State Average Benchmarks
Peer Average Claims28.0
Peer Average 30-Day Fills30.3
Peer Average Days Supply396
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 264.3% higher than the standard regional baseline profile for LA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,879.82 across this reporting matrix range.

Provider Avg Cost Per Claim

$18.43

State Avg Cost Per Claim

$15.03

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An anti-inflammatory 9-fluoro-glucocorticoid.

Therapeutic Applications

Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions, skin diseases, eye problems, breathing problems, bowel disorders, cancer, and immune system disorders. It is also used as a test for an adrenal gland disorder (Cushing's syndrome). Dexamethasone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions.

Lidocaine Hcl Viscous

Generic Formulation: Lidocaine HclSpecialty: Otolaryngology
Provider Metrics Summary
Total Claims 23
30-Day Fills 23.0
Days Supply 354
LA State Average Benchmarks
Peer Average Claims19.0
Peer Average 30-Day Fills19.9
Peer Average Days Supply151
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across LA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $390.05 across this reporting matrix range.

Provider Avg Cost Per Claim

$16.96

State Avg Cost Per Claim

$14.34

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used on the skin to stop itching and pain from certain skin conditions (such as scrapes, minor burns, eczema, insect bites) and to treat minor discomfort and itching caused by hemorrhoids and certain other problems of the genital/anal area (such as anal fissures, itching around the vagina/rectum). Some forms of this medication are also used to decrease discomfort or pain during certain medical procedures/exams (such as sigmoidoscopy, cystoscopy). Lidocaine is a local anesthetic that works by causing temporary numbness/loss of feeling in the skin and mucous membranes.

Nystatin

Generic Formulation: NystatinSpecialty: Otolaryngology
Provider Metrics Summary
Total Claims 12
30-Day Fills 12.0
Days Supply 111
LA State Average Benchmarks
Peer Average Claims24.0
Peer Average 30-Day Fills25.1
Peer Average Days Supply434
Conservative Utilization

This provider writes prescriptions for this formulation 50.0% less frequently than the standard regional baseline metric for practitioners inside LA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $237.46 across this reporting matrix range.

Provider Avg Cost Per Claim

$19.79

State Avg Cost Per Claim

$21.39

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Macrolide antifungal antibiotic complex produced by Streptomyces noursei, S. aureus, and other Streptomyces species. The biologically active components of the complex are nystatin A1, A2, and A3.

Therapeutic Applications

Nystatin is used to treat fungal skin infections. Nystatin is an antifungal that works by stopping the growth of fungus.

Oxycodone Hcl

Generic Formulation: Oxycodone HclSpecialty: Otolaryngology
Provider Metrics Summary
Total Claims 11
30-Day Fills 11.0
Days Supply 47
LA State Average Benchmarks
Peer Average Claims72.0
Peer Average 30-Day Fills72.7
Peer Average Days Supply1,740
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 84.7% less volume than the regional standard for practitioners inside LA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $93.66 across this reporting matrix range.

Provider Avg Cost Per Claim

$8.51

State Avg Cost Per Claim

$26.62

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A semisynthetic derivative of CODEINE.

Therapeutic Applications

This medication is used to help relieve moderate to severe pain. Oxycodone belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain.

Tramadol Hcl

Generic Formulation: Tramadol HclSpecialty: Otolaryngology
Provider Metrics Summary
Total Claims 18
30-Day Fills 18.0
Days Supply 94
LA State Average Benchmarks
Peer Average Claims74.0
Peer Average 30-Day Fills74.9
Peer Average Days Supply1,465
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 75.7% less volume than the regional standard for practitioners inside LA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $127.71 across this reporting matrix range.

Provider Avg Cost Per Claim

$7.10

State Avg Cost Per Claim

$6.52

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A narcotic analgesic proposed for severe pain. It may be habituating.

Therapeutic Applications

See also Warning section. This medication is used to help relieve moderate to moderately severe pain. Tramadol belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like DANIEL MARSHALL CUMMINS M.D., D.M.D provides transparency into local medical care patterns within Metairie, LA.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Oral & Maxillofacial Surgery** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.